Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature
BackgroundThis study aims to identify precise biomarkers for breast cancer to improve patient outcomes, addressing the limitations of traditional staging in predicting treatment responses.MethodsOur analysis encompassed data from over 7,000 breast canc…